New MS drug aims to quiet brain inflammation
NCT ID NCT06220669
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study tests an investigational drug called LY3541860 in 63 adults with relapsing multiple sclerosis (MS). The goal is to see if it can safely reduce the number of new active brain lesions compared to a placebo. Participants receive the drug or placebo for about 9 months, with an additional 6 months of follow-up. The study is not yet recruiting and is in Phase 2.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier Intercommunal - Site de Poissy
Poissy, 78303, France
-
Clinirem
Lublin, 20-064, Poland
-
Conquest Research LLC - Winter Park - ClinEdge - PPDS
Winter Park, Florida, 32789, United States
-
Consultants in Neurology
Northbrook, Illinois, 60062, United States
-
ETG Neuroscience - PPDS
Warsaw, 02-677, Poland
-
Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta-VIA MANGIAGALLI 3
Milan, 20133, Italy
-
Hope Neurology
Knoxville, Tennessee, 37922, United States
-
IBISMED Wielospecjalistyczne Centrum Medyczne
Zabrze, 41-800, Poland
-
M.A. - LEK A.M. Maciejowscy SC. Centrum Terapii SM
Katowice, 40-571, Poland
-
NEURO-MEDIC Sp. z o. o.
Katowice, 40-686, Poland
-
Nemocnica Ruzinov
Bratislava, 826 06, Slovakia
-
Neurocentrum Bydgoszcz sp. z o.o.
Bydgoszcz, 85-796, Poland
-
Niepubliczny Zaklad Opieki Zdrowotnej NEURO-KARD Ilkowski i Partnerzy Spolka Partnerska Lekarzy
Poznan, 61-853, Poland
-
Panhandle Research and Medical Clinic
Gulf Breeze, Florida, 32561, United States
-
Pauls Stradins Clinical Univeristy Hospital
Riga, LV-1002, Latvia
-
Premier Neurology
Greer, South Carolina, 29605, United States
-
ProNeuro Centrum Medyczne
Żory, 44-240, Poland
-
Queen's Medical Centre
Nottingham, NG7 2UH, United Kingdom
-
Sharlin Health and Neurology
Ozark, Missouri, 65721-5315, United States
-
Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala
Katowice, 40-060, Poland
Conditions
Explore the condition pages connected to this study.